1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Acoustic Enrichment of Heterogeneous Circulating Tumor Cells and Clusters from Metastatic Prostate Cancer Patients
(
- Contribution to journal › Article
- 2022
-
Mark
The STAT3 inhibitor GPB730 enhances the sensitivity to enzalutamide in prostate cancer cells
(
- Contribution to journal › Article
- 2021
-
Mark
Quantification of microRNA editing using two-tailed RT-qPCR for improved biomarker discovery
(
- Contribution to journal › Article
- 2019
-
Mark
The β2-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells
(
- Contribution to journal › Article
- 2015
-
Mark
Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate Cancer.
(
- Contribution to journal › Article
- 2014
-
Mark
Identification of plasma protein profiles associated with risk groups of prostate cancer patients.
(
- Contribution to journal › Article
-
Mark
REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer.
(
- Contribution to journal › Article
-
Mark
Galiellalactone is a Direct Inhibitor of STAT3 in Prostate Cancer Cells.
(
- Contribution to journal › Article
- 2013
-
Mark
High Expression of Midkine in the Airways of Patients with Cystic Fibrosis.
(
- Contribution to journal › Article
- 2011
-
Mark
Effects of NOD-like receptors in human B lymphocytes and crosstalk between NOD1/NOD2 and Toll-like receptors.
(
- Contribution to journal › Article